Skip to main content
Barry Hafkin, MD, Infectious Disease, Austin, TX

BarryHafkinMD

Infectious Disease Austin, TX

Principal of B Hafkin and Associates Inc.

Dr. Hafkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hafkin's full profile

Already have an account?

Education & Training

  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 1973

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1973 - 2019
  • CA State Medical License
    CA State Medical License 1977 - 2015

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. For Novel Antibiotic, Contezolid Acefosamil
    MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. For Novel Antibiotic, Contezolid AcefosamilNovember 26th, 2018
  • MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil
    MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid AcefosamilSeptember 21st, 2018
  • MicuRx Initiates Phase 1 Clinical Trial in U.S. For Novel Antibiotic Agent MRX-4
    MicuRx Initiates Phase 1 Clinical Trial in U.S. For Novel Antibiotic Agent MRX-4November 30th, 2016